Literature DB >> 23793963

Opinions from the experts: exploring what prostate cancer patients should know about post-operative radiotherapy.

Laura D'Alimonte1, Kaitlin Koo, Emily Chen, Deb Feldman-Stewart, Arlene Court, Margaret Fitch, Lisa Di Prospero, John Maamoun, Alex Kiss, Ewa Szumacher.   

Abstract

The present study investigated health professionals' opinions about important questions that should be discussed with patients who may require post-prostatectomy radiotherapy. A 74-question survey was conducted among radiation oncologists, urologists, nurses, and radiation therapists involved in the care of prostate cancer patients. Survey questions covered six domains: understanding my situation and prostate cancer diagnosis, making a decision, radiotherapy: procedures involved, potential benefits, side effects, and my support network during radiation treatment. Respondents rated the importance of addressing these questions as either essential, important, no opinion, or avoid with a hypothetical post-prostatectomy case. The majority of questions were rated as either essential or important. There was disagreement between professions on essential questions, mostly between nurses and urologists in the side-effects domain. There was agreement between all professions regarding which questions should be avoided.

Entities:  

Mesh:

Year:  2013        PMID: 23793963     DOI: 10.1007/s13187-013-0494-9

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  25 in total

1.  Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study.

Authors:  L C Harlan; A Potosky; F D Gilliland; R Hoffman; P C Albertsen; A S Hamilton; J W Eley; J L Stanford; R A Stephenson
Journal:  J Natl Cancer Inst       Date:  2001-12-19       Impact factor: 13.506

2.  What prostate cancer patients should know: variation in professionals' opinions.

Authors:  D Feldman-Stewart; M D Brundage; C Hayter; P Groome; J C Nickel; H Downes; W J Mackillop
Journal:  Radiother Oncol       Date:  1998-11       Impact factor: 6.280

3.  An evaluation of radical prostatectomy at Veterans Affairs Medical Centers: time trends and geographic variation in utilization and outcomes.

Authors:  T J Wilt; D C Cowper; J K Gammack; D R Going; S Nugent; S J Borowsky
Journal:  Med Care       Date:  1999-10       Impact factor: 2.983

4.  Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.

Authors:  Bruce J Trock; Misop Han; Stephen J Freedland; Elizabeth B Humphreys; Theodore L DeWeese; Alan W Partin; Patrick C Walsh
Journal:  JAMA       Date:  2008-06-18       Impact factor: 56.272

5.  Agreement between prostate cancer patients and their clinicians about utilities and attribute importance.

Authors:  Arthur S Elstein; Gretchen B Chapman; Joan S Chmiel; Sara J Knight; Cheeling Chan; Robert B Nadler; Timothy M Kuzel; Amy K Siston; Charles L Bennett
Journal:  Health Expect       Date:  2004-06       Impact factor: 3.377

Review 6.  Patient decision aids for prostate cancer treatment: a systematic review of the literature.

Authors:  Grace A Lin; David S Aaronson; Sara J Knight; Peter R Carroll; R Adams Dudley
Journal:  CA Cancer J Clin       Date:  2009-10-19       Impact factor: 508.702

7.  Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.

Authors:  Thomas Wiegel; Dirk Bottke; Ursula Steiner; Alessandra Siegmann; Reinhard Golz; Stephan Störkel; Norman Willich; Axel Semjonow; Rainer Souchon; Michael Stöckle; Christian Rübe; Lothar Weissbach; Peter Althaus; Udo Rebmann; Tilman Kälble; Horst Jürgen Feldmann; Manfred Wirth; Axel Hinke; Wolfgang Hinkelbein; Kurt Miller
Journal:  J Clin Oncol       Date:  2009-05-11       Impact factor: 44.544

8.  Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

Authors:  Andrew J Stephenson; Peter T Scardino; Michael W Kattan; Thomas M Pisansky; Kevin M Slawin; Eric A Klein; Mitchell S Anscher; Jeff M Michalski; Howard M Sandler; Daniel W Lin; Jeffrey D Forman; Michael J Zelefsky; Larry L Kestin; Claus G Roehrborn; Charles N Catton; Theodore L DeWeese; Stanley L Liauw; Richard K Valicenti; Deborah A Kuban; Alan Pollack
Journal:  J Clin Oncol       Date:  2007-05-20       Impact factor: 44.544

9.  Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer.

Authors:  Matthew S Katz; Michael J Zelefsky; Ennapadam S Venkatraman; Zvi Fuks; Amanda Hummer; Steven A Leibel
Journal:  J Clin Oncol       Date:  2003-02-01       Impact factor: 44.544

10.  Doctors' and patients' preferences for participation and treatment in curative prostate cancer radiotherapy.

Authors:  Peep F M Stalmeier; Julia J van Tol-Geerdink; Emile N J Th van Lin; Erik Schimmel; Henk Huizenga; Willem A J van Daal; Jan-Willem Leer
Journal:  J Clin Oncol       Date:  2007-07-20       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.